Literature DB >> 9067697

Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation.

O Guckelberger1, W O Bechstein, R Neuhaus, R Luesebrink, H P Lemmens, B Kratschmer, S Jonas, P L Neuhaus.   

Abstract

In a retrospective study the records of 302 adult patients (167 male, 135 female) after orthotopic liver transplantation (OLT) with a minimum follow-up of 6 months (median follow-up 18 months, maximum 5 yr) were reviewed with regard to cardiovascular risk factors. In 197 patients data concerning the occurrence of arterial hypertension, hyperglycemia, or hypercholesterolemia prior to OLT were available. We found a highly significant increase of cardiovascular risk factors following OLT. Obesity was found in 17.4% of male and 22.2% of female recipients after OLT. Hypercholesterolemia was evident in 66.2% of liver graft recipients. Hypertriglyceridemia occurred in 49.7% of all male patients. In females there was a significantly different prevalence of hypertriglyceridemia comparing patients with a follow-up period up to 2 yr and more than 2 yr (50% vs. 24.6%, p = 0.018). Nearly 45% of all patients met the criteria for arterial hypertension, with a slight increase in male patients beyond the second year of survival (p = 0.094). Hyperglycemia had a significantly higher frequency in male than in female patients (30.5% vs. 10.4%, p < 0.005). Furthermore we observed a clear trend towards reduction of occurrence of hyperglycemia more than 24 months after OLT, but not reaching statistical significance. No correlation was detected when serum levels of triglycerides, and cholesterol, body-mass-index, and arterial blood pressure were compared with applied dosages of immunosuppressive agents [cyclosporin A (CyA), tacrolimus, and prednisolone]. Only decreasing tacrolimus application was significantly correlated with decreasing glucosemia (p = 0.041). Patients receiving tacrolimus instead of CyA as primary immunosuppressant showed a significantly lower prevalence of hypercholesterolemia. Even hypertension, hyperglycemia, hypertriglyceridemia, and obesity had a lower occurrence in patients treated with tacrolimus although not reaching statistical significance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067697

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  12 in total

1.  Caring for the liver transplant recipient.

Authors:  R K Zetterman
Journal:  Curr Gastroenterol Rep       Date:  1999-06

2.  Lipoprotein-apolipoprotein changes in renal transplant recipients.

Authors:  Maurizio Cassader; Gianluca Ruiu; Roberto Gambino; Natalina Alemanno; Giorgio Triolo; Fabrizio Veglia; Gianfranco Pagano
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

3.  Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report.

Authors:  Paolo Gentileschi; Marco Venza; Domenico Benavoli; Francesca Lirosi; Ida Camperchioli; Marco D'Eletto; Alessandra Lazzaro; Vito M Stolfi; Alessandro Anselmo; Nicola Di Lorenzo; Giuseppe Tisone; Achille L Gaspari
Journal:  Obes Surg       Date:  2009-06-09       Impact factor: 4.129

4.  Office-Based Weight Loss Counseling Is Ineffective in Liver Transplant Recipients.

Authors:  Samarth S Patel; Mohammad B Siddiqui; Anchalia Chadrakumaran; Masoud Faridnia; Fei-Pi Lin; Jose Hernandez Roman; Salvatore Carbone; John Laurenzo; Joseph Clinton; Danielle Kirkman; Susan Wolver; Francesco Celi; Chandra Bhati; Mohammad S Siddiqui
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

5.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

6.  What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

Authors:  A Jain; J Reyes; R Kashyap; S Rohal; K Abu-Elmagd; T Starzl; J Fung
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

7.  Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors.

Authors:  Seyed Mohsen Dehghani; Seyed Ali Reza Taghavi; Ahad Eshraghian; Siavash Gholami; Mohammad Hadi Imanieh; Mohammad Reza Bordbar; Seyed Ali Malek-Hosseini
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

Review 8.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Metabolic syndrome after liver transplantation: preventable illness or common consequence?

Authors:  Eric R Kallwitz
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

10.  Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats.

Authors:  M A Morsy
Journal:  Indian J Pharmacol       Date:  2011-11       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.